DermBiont

Arcutis Biotherapeutics

This biopharmaceutical company develops and commercialises topical treatments for patients with chronic inflammatory skin diseases such as psoriasis, eczema, and seborrhoeic dermatitis.

Dermira

This biopharmaceutical company develops and commercialises medical dermatology treatments for patients with chronic skin conditions such as excessive sweating and atopic dermatitis.

Arcutis

This company develops and commercialises topical treatments for patients living with chronic immune-mediated dermatological diseases including psoriasis, seborrhoeic dermatitis and atopic dermatitis.

Brickell Biotech

This pharmaceutical company develops prescription therapeutics for patients with skin diseases, such as hyperhidrosis, atopic dermatitis, and acne.

Blueberry Therapeutics

This clinical-stage biotechnology company develops nanomedicine therapies for patients with common dermatological and fungal infections using a proprietary delivery platform.

Xinnate

Xinnate develops peptide-based topical therapies for patients with inflammatory skin diseases and chronic wounds, primarily focusing on treating epidermolysis bullosa.

KOBIOLABS

This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.

Torqur

This clinical-stage biotechnology company develops PI3K and mTOR inhibitor therapies for patients with oncology and dermatology indications.